Earnings Per Share |
(14) Earnings Per Share
For the three months ended September 30, 2024 and 2023, basic and diluted
net loss per share are calculated as follows:
| |
Three Months Ended September 30, | |
| |
2024 | | |
2023 | |
Basic loss per share | |
| | |
| |
Net loss for the period - numerator | |
$ | (1,973,946 | ) | |
$ | (1,975,368 | ) |
Weighted average common stock outstanding - denominator | |
| 10,065,920 | | |
| 10,065,920 | |
Net loss per share | |
$ | (0.20 | ) | |
$ | (0.20 | ) |
| |
| | | |
| | |
Diluted loss per share | |
| | | |
| | |
Net loss for the period- numerator | |
$ | (1,973,946 | ) | |
$ | (1,975,368 | ) |
Weighted average common stock outstanding - denominator | |
| 10,065,920 | | |
| 10,065,920 | |
| |
| | | |
| | |
Effect of dilution | |
| - | | |
| - | |
Weighted average common stock outstanding - denominator | |
| 10,065,920 | | |
| 10,065,920 | |
Diluted loss per share | |
$ | (0.20 | ) | |
$ | (0.20 | ) |
For the nine months ended September 30, 2024 and 2023, basic and diluted
net loss per share are calculated as follows:
| |
Nine Months Ended
September 30, | |
| |
2024 | | |
2023 | |
Basic loss per share | |
| | |
| |
Net loss for the period - numerator | |
$ | (5,798,229 | ) | |
$ | (5,962,026 | ) |
Weighted average common stock outstanding - denominator | |
| 10,065,920 | | |
| 10,065,920 | |
Net loss per share | |
$ | (0.58 | ) | |
$ | (0.59 | ) |
| |
| | | |
| | |
Diluted loss per share | |
| | | |
| | |
Net loss for the period - numerator | |
$ | (5,798,229 | ) | |
$ | (5,962,026 | ) |
Weighted average common stock outstanding - denominator | |
| 10,065,920 | | |
| 10,065,920 | |
Effect of dilution | |
| - | | |
| - | |
Weighted average common stock outstanding - denominator | |
| 10,065,920 | | |
| 10,065,920 | |
Diluted loss per share | |
$ | (0.58 | ) | |
$ | (0.59 | ) |
For the three and nine months ended September 30, 2024 and 2023 there
were no securities with dilutive effect issued and outstanding.
|